Deadline: 01 Sep 2026
France
Ref. No.: 23102137
EMD:Ref Document
Bid Value: Ref Document
90 Days Left
Deadline: 01 Sep 2026
France
Ref. No.: 23101784
EMD:Ref Document
Bid Value: Ref Document
90 Days Left
Deadline: 30 Nov 2027
Germany
Ref. No.: 23096995
EMD:Ref Document
Bid Value: Ref Document
545 Days Left
Deadline: 15 Dec 2027
Germany
Ref. No.: 23095626
EMD:Ref Document
Bid Value: Ref Document
560 Days Left
Deadline: 30 Nov 2027
Germany
Ref. No.: 23094967
EMD:Ref Document
Bid Value: Ref Document
545 Days Left
Deadline: 30 Nov 2027
Germany
Ref. No.: 23094504
EMD:Ref Document
Bid Value: Ref Document
545 Days Left
Deadline: 30 Nov 2027
Germany
Ref. No.: 23093472
EMD:Ref Document
Bid Value: Ref Document
545 Days Left
Deadline: 30 Nov 2027
Germany
Ref. No.: 23092890
EMD:Ref Document
Bid Value: Ref Document
545 Days Left
Deadline: 30 Apr 2027
Germany
Ref. No.: 23091181
EMD:Ref Document
Bid Value: Ref Document
331 Days Left
Deadline: 30 Nov 2027
Germany
Ref. No.: 23091149
EMD:Ref Document
Bid Value: Ref Document
545 Days Left
Deadline: 30 Nov 2027
Germany
Ref. No.: 23088522
EMD:Ref Document
Bid Value: Ref Document
545 Days Left
Deadline: 30 Nov 2027
Germany
Ref. No.: 23087241
EMD:Ref Document
Bid Value: Ref Document
545 Days Left
Deadline: 30 Nov 2027
Germany
Ref. No.: 23085491
EMD:Ref Document
Bid Value: Ref Document
545 Days Left
Open House Drug Discount Agreements For The Active Ingredient Denosumab Trade Name Xgeva Atc M05Bx04
Deadline: 30 Apr 2027
Germany
Ref. No.: 23085170
EMD:Ref Document
Bid Value: Ref Document
331 Days Left
Deadline: 09 Dec 2026
United States
Ref. No.: 23082321
EMD:Ref Document
Bid Value: Ref Document
189 Days Left